Related Experiment Video
Updated: Nov 9, 2025

09:01
Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
7.4K
Longitudinal CSF Findings in Autoimmune Encephalitis-A Monocentric Cohort Study
Tobias Zrzavy1, Romana Höftberger2, Isabella Wimmer1
1Department of Neurology, Medical University of Vienna, Vienna, Austria.
Frontiers in Immunology
|April 8, 2021
Summary
Autoimmune encephalitis (AIE) diagnosis can be challenging, as routine cerebrospinal fluid (CSF) analysis may appear normal in many patients. Oligoclonal band status in anti-NMDAR AIE may indicate prognosis.
Area of Science:
- Neurology
- Immunology
- Clinical Diagnostics
Background:
- Autoimmune encephalitis (AIE) presents with diverse symptoms, mimicking other neurological and psychiatric conditions, complicating diagnosis.
- Cerebrospinal fluid (CSF) analysis is crucial for differential diagnosis and identifying specific antibodies in AIE.
- Understanding CSF findings in antibody-associated AIE is essential for timely and accurate diagnosis.
Purpose of the Study:
- To describe initial and serial CSF findings in a cohort of 33 patients with antibody-associated AIE.
- To evaluate the utility of routine CSF parameters and oligoclonal bands (OCBs) in diagnosing and monitoring AIE.
- To explore the potential prognostic value of OCB status in anti-NMDAR AIE.
Main Methods:
- Monocentric cohort study analyzing CSF from 33 patients with confirmed antibody-associated AIE.
- Included analysis of routine CSF parameters (cell count, protein levels) and oligoclonal bands (OCBs).
- Serial CSF analyses were performed to track changes over time and correlate with clinical status.
Main Results:
- 12.1% of AIE patients had normal routine CSF parameters at diagnosis.
- Elevated protein levels (60.6%) and OCBs (45.4%) were common findings.
- Serial CSF analysis showed a trend toward normalization, with relapses linked to increased cells and protein; OCB conversion correlated with improvement in anti-NMDAR AIE.
Conclusions:
- A significant proportion of AIE patients may have normal CSF findings, potentially delaying diagnosis if antibody testing is not prioritized.
- OCB status in anti-NMDAR AIE patients may serve as a potential prognostic biomarker, warranting further investigation.
- Routine CSF analysis provides valuable diagnostic and monitoring information in AIE, but antibody identification remains critical.

